Washington, District of Columbia 20447 Email: rshelbourne@acf.hhs.gov Phone: (202) 401-5150 Fax: (202) 401-5554 Website Address: http://www.acf.hhs.gov/programs/ofa/tanf/index.html RELATED PROGRAMS: 93.558 Temporary Assistance for Needy Families; 93.594 Tribal Work Grants; 93.595 Welfare Reform Research, Evaluations and National Studies; 93.667 Social Services Block Grant EXAMPLES OF FUNDED PROJECTS: Not Applicable. CRITERIA FOR SELECTING PROPOSALS: Not Applicable. 93.717 ARRA - PREVENTING HEALTHCARE-ASSOCIATED INFECTIONS ARRA Preventing Healthcare-Associated Infections FEDERAL AGENCY: Centers for Disease Control and Prevention, Department of Health and Human Services AUTHORIZATION: Health Service Act Sections 301(a)[42 U.S.C. 241(a)] American Recovery and Reinvestment Act of 2009, Public Law 111-5, Public Law 111-5, 42 U.S.C 241(a). OBJECTIVES: This funding was appropriated under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5). The ARRA funds are intended to reduce preventable healthcare-associated infections through State health department efforts to prevent HAIs including leveraging the National Health Care Safety Network to support the dissemination of HHS evidence-based practices within hospitals ($40 million). Specific goals include: (1) progress towards prevention targets (e.g., 50-70% reduction in bloodstream infections); (2) use of the metrics and supporting systems to assess progress towards meeting the targets; (3) broad implementation of current evidence-based prevention guideline recommendations; (4) develop and implement state public health-healthcare HAI prevention collaboratives to implement prioritized HAI prevention recommendations using CDCs NHSN as the measurement system; (5) enhance and expand participation by hospitals and other healthcare facilities in the NHSN to facilitate reporting of appropriate HAI metrics and progress toward five-year prevention targets to state health departments and CDC, HHS, and other HHS OPDIVS; (6) build a public health workforce in health departments who can coordinate state-wide initiatives to ensure progress towards five-year national prevention targets; (7) assist States in the development and submission of state HAI prevention plans; (8) quickly expand its infrastructure to address a broader array of HAI epidemiology; (9) provide additional training for EIP state staff on HAI epidemiology and surveillance; (10) develop and implement enhanced surveillance tools and methods, and add staff for targeted two year projects. TYPES OF ASSISTANCE: Cooperative Agreements USES AND USE RESTRICTIONS: CDC will provide 99.5% of the funds to eligible states using the following existing Cooperative Agreements: the Epidemiology and Laboratory Capacity for Infectious Disease program, and the Emerging Infections Program. Project funds may be used for costs associated with planning, organizing, conducting and supporting programs directed toward preventing healthcare associated infections, and for the implementation of other program elements as described in Section :050: above. These funds may be used for the preservation of jobs necessary to build capacity in state and local health departments related to healthcare associated infection prevention. See above. Applicant Eligibility: See Index. Beneficiary Eligibility: See Index. Credentials/Documentation: Applicants should document the need for assistance, state the objectives of the project, outline the method of operation, describe the evaluation procedures, describe plans for sustaining the impact of ARRA investments beyond the federal funding provided in the next two years and provide a budget with justification of funds requested. Costs will be determined in accordance with OMB Circular No. A-87 for State and local governments. For nonprofit recipients, costs will be determined in accordance with HHS Regulations 45 CFR 74, Subpart Q. This program is excluded from coverage under OMB Circular No. A-87. Preapplication Coordination: Preapplication coordination is not required. Environmental impact information is not required for this program. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review. Application Procedures: This program is excluded from coverage under OMB Circular No. A-102. This program is excluded from coverage under OMB Circular No. A-110. Applicants must download the SF424 (R&R) application forms and SF424 (R&R) Application Guide for this requirement through Grants.gov/Apply. Only the forms package directly attached to a specific Funding Opportunity Announcement (FOA) can be used. Applicants will not be able to use any other SF424 (R&R) forms (e.g., sample forms, forms from another FOA) although some of the "Attachment" files may be useable for more than one FOA. If an applicant does not have access to the Internet, or if they have difficulty accessing the forms online, contact the CDC Procurement and Grants Office Technical Information Management Section (PGOTIMS) staff. For this, or further assistance, contact PGO TIMS: Telephone (770) 488-2700, Email: PGOTIM@cdc.gov. HHS/CDC Telecommunications for the hearing impaired: TTY 770-488-2783. The standard application forms must be used for this program, as furnished by CDC and required by 45 CFR 92 for State and local governmental agencies, and by OMB Circular No. A-110 for nongovernmental applicants. This program is subject to the provisions of 45 CFR 92 for State and local governments and OMB Circular No. A-110 for nonprofit organizations. Award Procedure: All applications that are complete and responsive to non-competitive supplemental grant announcements will be evaluated for scientific and technical merit and receive support. Support will be need based and may be formula driven. Applications that are complete and responsive to competitive supplemental grant and cooperative agreement announcements will undergo an objective review process, receive a written critique and be scored according to published review criteria. Successful applicants will receive a Notice of Award (NOA) from the CDC Procurement and Grants Office. The NOA shall be the only binding, authorizing document between the recipient and CDC. The NOA will be signed by an authorized Grants Management Officer. Deadlines: Contact the headquarters or regional office, as appropriate, for application Range of Approval/Disapproval Time: Not Applicable. Renewals: Renewals will be based upon availability of funding under the American Recovery and Reinvestment Act. Formula and Matching Requirements: This program has no statutory formula. This program has no matching requirements. This program does not have MOE requirements. Project Period: until December 29, 2011. Budget Period: variable. See the following for information on how assistance is awarded/released: No information provided. Reports: Recipients of Federal awards from funds authorized under Division A of the ARRA must comply with all requirements specified in Division A of the ARRA (Public Law 111-5), including reporting requirements outlined in Section 1512 of the Act. For purposes of reporting, ARRA recipients must report on ARRA sub-recipient (sub-grantee and sub-contractor) activities as specified below. Not later than 10 days after the end of each calendar quarter, starting with the quarter ending June 30, 2009 and reporting by July 10, 2009, the recipient must submit quarterly reports to HHS that will be posted to Recovery.gov, containing the following information: (a) The total amount of ARRA funds under this award; (b) The amount of ARRA funds received under this award that were obligated and expended to projects or activities; (c) The amount of unobligated award balances; (d) A detailed list of all projects or activities for which ARRA funds under this award were obligated and expended, including: (1) the name of the project or activity; (2) a description of the project or activity; (3) an evaluation of the completion status of the project or activity; (4) an estimate of the number of jobs created and the number of jobs retained by the project or activity; and (5) for infrastructure investments made by State and local governments, the purpose, total cost, and rationale of the agency for funding the infrastructure investment with funds made available under this Act, and the name of the person to contact at the agency if there are concerns with the infrastructure investment. (e) Detailed information on any sub-awards (sub-contracts or sub-grants) made by the grant recipient to include the data elements required to comply with the Federal Funding Accountability and Transparency Act of 2006 (Public Law 109-282). For any sub-award equal to or larger than $25,000, the following information will be required: (1) the name of the entity receiving the sub-award; (2) the amount of the sub-award; (3) the transaction type; (4) the North American Industry Classification System code or Catalog of Federal Domestic Assistance (CFDA) number; (5) program source; (6) an award title descriptive of the purpose of each funding action; (7) the location of the entity receiving the award; (8) the primary location of performance under the award, including the city, State, congressional district, and country; and (9) a unique identifier of the entity receiving the award and of the parent entity of the recipient, should the entity be owned by another entity. (f) All sub-awards less than $25,000 or to individuals may be reported in the aggregate, as prescribed by HHS. (g) Recipients must account for each ARRA award and sub-award (sub-grant and sub-contract) separately. Recipients will draw down ARRA funds on an award-specific basis. Pooling of ARRA award funds with other funds for drawdown or other purposes is not permitted. (h) Recipients must account for each ARRA award separately by referencing the assigned CFDA number for each award. Additional reporting requirements will detailed in Funding Opportunity Announcements and included in award notices. Final financial status and performance reports are required 90 days after the end of the project period. No cash reports are required. No progress reports are required. No expenditure reports are required. No performance monitoring is required. Audits: In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. An organization that expends $500,000 or more in a year in Federal awards shall have a single or program-specific audit conducted for that year in accordance with the provisions of OMB Circular A-133, Audit of States, Local Governments, and Non-Profit Org Records: Financial records, supporting documents, statistical records, and all other records pertinent to the grant program shall be retained for a minimum of 3 (Cooperative Agreements) FY 08 $0; FY 09 est $40,000,000; FY 10 est $0 PROGRAM ACCOMPLISHMENTS: Fiscal Year 2008: The Epidemiology and Laboratory Capacity (ELC) for Infectious Disease program plays a critical role in strengthening our nations infrastructure for preventing and controlling infectious diseases. The program builds epidemiology, laboratory, and information systems capacity in all 50 states to assist frontline state programs respond to infectious disease outbreaks, address the increasing threat of antimicrobial resistance, and detect and respond to new and emerging infectious diseases. As states are in different stages of implementing HAI monitoring and prevention programs, ELC funding would be flexible in its applications; however monies would be directed specifically toward the goals of preventing healthcare associated infections. The Emerging Infections Programs (EIPs) are a critical part of our nations infrastructure for public health work in infectious diseases. Established in 1995, the EIPS consist of 10 centers of excellence across the US that are collaborations among state health agencies, academic institutions, CDC, and other federal agencies. Collectively, they form a specialized network of research centers for infectious disease work that goes beyond the routine functions of health departments. The EIP networks unique strength and contribution lies in its ability to quickly translate surveillance and research activities into informed policy and public health practice. CDC has supported and been an active participant in the collaborative effort led by HHS to develop the HHS Action Plan to Prevent Healthcare Associated Infections. The HHS Action Plan sets specific targets for monitoring and preventing HAIs nationally and represents a national blueprint for prevention. CDC has played an integral role in the development and implementation of the HHS Action Plan, including chairing the Prevention and Implementation working group and co-chairing the Information Systems and Technology working group, while actively participating in the three other workgroups. In September 2008, CDC hosted a meeting of experts to help define prevention targets and metrics for the Action Plan. CDC continues to work closely with HHS and the other agencies to implement the plan. CDC has a broad range of activities that are crucial to successfully implement the HHS plan. These activities can be categorized as: 1) tracking and monitoring HAIS; 2) developing guidelines for prevention; 3) implementation of prevention strategies; 4) developing new strategies for prevention; 5) identifying and responding to new and emerging threats. CDCS NHSN is a tool for tracking and prevention of HAIs that incorporates HICPAC practice guidelines, uses validated standardized definitions and protocols, and allows facilities to analyze, share, and compare their data with that of others. NHSN is used by over 2000 healthcare facilities in all 50 states, and continues to expand. Since 1990, facilities reporting to NHSN have seen significant reductions of up to 70% in rates of catheter associated urinary tract infections (CAUTI) in ICUS. From 1997 to 2007, hospitals participating in CDCS NHSN have decreased bloodstream infections by up to 50%. A total of 10,600 device-associated infections are estimated to have been prevented, and at least 1,300 lives are estimated to have been saved. CDC has demonstrated dramatic success in preventing and reducing HAIS through implementation of CDC guidelines. Through CDC supported efforts in Southwestern Pennsylvania, local hospitals have successfully reduced bloodstream infections by as much as 70 percent by fully implementing CDC prevention recommendations. Similar success was observed when Michigan fully implemented CDC guidelines in more than 100 ICUs. CDC funded and collaborated with the Pittsburgh VA Medical Center to prevent MRSA infections using CDC recommendations. These efforts led to greater than 60% reductions in MRSA rates, and to collaboration among healthcare facilities in southwestern Pennsylvania on a regional MRSA initiative. The Veterans Health Administration launched a national MRSA prevention initiative involving every Veterans Health Administration hospital in the country modeled after Pennsylvanias success. These and other prevention implementation examples demonstrate the savings in lives and healthcare costs that can result from national implementation of evidence-based HAI prevention programs. Fiscal Year 2009: No Current Data Available Fiscal Year 2010: No Current Data Available REGULATIONS, GUIDELINES, AND LITERATURE: Regulations governing this program are published under 42 CFR 55 b. 45 CFR 92, DHHS Publication No. (OASH) 94-50,000, (Rev.) April 1, 1994, is available. Regional or Local Office: None. Headquarters Office: Joni Young National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Department of Health and Human Services, 1600 Clifton Road, NE., Mailstop A07, Atlanta, Georgia 30333 Email: JYoung@cdc.gov Phone: (404) 639-4025 Fax: (404) 639-4043 Website Address: http://www.cdc.gov/; and www.Grants.gov RELATED PROGRAMS: 93.283 Centers for Disease Control and Prevention_Investigations and Technical Assistance EXAMPLES OF FUNDED PROJECTS: Not Applicable. CRITERIA FOR SELECTING PROPOSALS: Funding would be specifically directed to state health departments for HAI activities and would not be available for other non-related infectious disease activities. For state applicants to be eligible they will have to outline a plan for reporting progress toward HHS Action Plan Prevention Targets using specified metrics, either by participating in NHSN or by using NHSN definitions and surveillance methods in systems compatible with NHSN. CDC will require state applicants to specifically address in their applications state plans for sustaining the impact of ARRA investments beyond the federal funding provided in the next two years. Specifically, states will need to demonstrate a continued plan for progress toward meeting HHS Action Plan prevention targets as demonstrated through reporting metrics outlined in the Plan. Other criteria will be listed in individual funding opportunity announcements. [ts1]This Program requires Congressional Notification. Not Approved. 93.718 HEALTH INFORMATION TECHNOLOGY REGIONAL EXTENSION CENTERS PROGRAM FEDERAL AGENCY: Office of the Secretary, Department of Health and Human Services Section 3012(c) of the Public Health Service Act (PHSA), as added by Section Establish Health Information Technology Regional Extension Centers to identify and disseminate best practices and provide technical assistance supporting the adoption and meaningful use of health IT to improve care quality while protecting patient privacy. The statutory objective of the regional centers is to enhance and promote the adoption of health information technology through means specified in PHSA 3012(c)(3). TYPES OF ASSISTANCE: Cooperative Agreements (Discretionary Grants) USES AND USE RESTRICTIONS: Funds may be used for the initial and operating expenses incurred in establishing and operating a regional center that provides technical assistance services to providers seeking to adopt, implement, and/or effectively use certified electronic health records (EHR) technology. The assistance supported under this health information technology extension program, and carried out by regional centers, is technical assistance and consulting service to providers, and does not include funding to the providers. Applicant Eligibility: None Beneficiary Eligibility: None Credentials/Documentation: No Credentials or documentation are required. This program is excluded from coverage under OMB Circular No. A-87. Preapplication Coordination: Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372. Application Procedures: This program is excluded from coverage under OMB Circular No. A-102. a program announcement. The availability of this announcement will be Following objective review of applications, those applicants whose applications have been selected by the Secretary of HHS (or designee) for funding will receive a Notice of Award signed by an HHS Grants Management Officer. The Notice of Award, which is sent to the applicants Authorized Organizational Representative, is the only official notification of award. Unsuccessful applicants will be advised by letter. Deadlines: Contact the headquarters or regional office, as appropriate, for application deadlines. Range of Approval/Disapproval Time: Appeals: Not Applicable. Renewals: Not Applicable. Formula and Matching Requirements: This program has no statutory formula. Matching Requirements: PHSA 3012(c)(5) states that the Secretary may not provide more than 50 percent of the capital and annual operating and maintenance funds required to create and maintain such a center, except in an instance of national economic conditions which would render this cost-share requirement detrimental to the program and upon notification to Congress as to the justification to waive the cost-share requirements. The Secretary has determined that a 50 percent cost-share requirement on an annual basis is not in the best interest of the program. Instead, the Secretary has structured a funding partnership between HHS and recipients, as indicated in the Program Announcement. This program does not have MOE requirements. Length and Time Phasing of Assistance: PHSA 3012(c)(5), as added by ARRA, specifies that the Secretary may provide financial support to any regional center created under PHSA 3012(c) for a period not to exceed 4 years. Awards are expected to be for two, 2-year budget periods and a four year project period. See the following for information on how assistance is awarded/released: Subject to meeting performance requirements. Reports: Program report requirements, if applicable, will be identified in the Program Announcement. Cash report requirements, if applicable, will be identified in the Program Announcement. Recipients of Federal awards from funds authorized under Division A of the ARRA must comply with all requirements specified in Division A of the ARRA (Public Law 111-5), including reporting requirements outlined in Section 1512 of the Act. ARRA reports will be required quarterly. For purposes of reporting, ARRA recipients must also report on ARRA sub-recipient (sub-grantees and sub-contractors under the cooperative agreement) activities. Reporting requirements will be detailed in the program announcement and included in award notices. The frequency of interim progress reports and financial status reports will be identified in the program announcement and will be submitted no later than 30 days following the end of the reporting period to which they pertain. The final progress report and final financial status report are due no later than 90 days after the end of the project period. ARRA reporting and agency programmatic reporting provisions will require awardees to evaluate performance in view of stated objectives. Audits: In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. Records: Grantees are required to maintain grant accounting records for a minimum of 3 years from the submission date of the final financial report. If any litigation, claim, negotiation, audit or other action involving the record has been started before the expiration of the 3-year period, the records shall be retained until the completion of the action and resolution of all issues which arise from it or until the end of the regular 3-year period, whichever is later. Account Identification: 75-0130-0-1-551. Obligations: (Cooperative Agreements (Discretionary Grants)) FY 08 $0; FY 09 est $0; FY 10 est $598,000,000 Range and Average of Financial Assistance: Awards for regional centers are expected to average $8.5M. Not Applicable. REGULATIONS, GUIDELINES, AND LITERATURE: This program is subject to the provisions of 45 CFR part 74 and the HHS Grants Policy Statement located at: http://www.hhs.gov/grantsnet/adminis/gpd/index.htm. There are no program regulations. Regional or Local Office: None. Headquarters Office: Rachel Nelson 200 Independence Avenue, SW, Suite 729D, Washington, District of Columbia 20201 Email: regional-center-applications@hhs.gov Phone: (202) 690-7151 Website Address: http://healthit.hhs.gov RELATED PROGRAMS: Not Applicable. EXAMPLES OF FUNDED PROJECTS: Not Applicable. CRITERIA FOR SELECTING PROPOSALS: Specific, detailed criteria for determining merit of applications will be made available in the program announcement(s) for this program. In general, all applicants are required to demonstrate capability to achieve the goals, purposes, and objectives of the program consistent with applicable statutory provisions. 93.719 ARRA - STATE GRANTS TO PROMOTE HEALTH INFORMATION TECHNOLOGY FEDERAL AGENCY: Office of the Secretary, Department of Health and Human Services American Recovery and Reinvestment Act (ARRA) of 2009, Division A, Title Promote the electronic movement and use of health information among organizations using nationally recognized interoperability standards. Enable providers to qualify for Medicare and Medicaid financial incentives, authorized by ARRA, by providing health information exchange that meets meaningful use requirements. Improve health care quality and efficiency. Establish a technical infrastructure to support health care reform. TYPES OF ASSISTANCE: Cooperative Agreements (Discretionary Grants) This state-based program is targeted specifically towards developing widespread and sustainable health information exchange (HIE) capacity in support of the meaningful use definition that qualifies providers for the Medicare and Medicaid incentive payments. This program also supports state public health programs to ensure that public health stakeholders prepare for HIE and mobilizes clinical data needed for consumer engagement and health reform across all states. Applicant Eligibility: None Beneficiary Eligibility: Credentials/Documentation: State governments and Qualified State-Designated Entities are eligible to apply. The program will require a letter from the Governor establishing the Qualified State Designated Entity, if applicable. Documentation must be provided in accordance with the requirements of all applicable OMB Circulars. OMB Circular No. A-87 applies to this program. Preapplication Coordination: Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372. Application Procedures: OMB Circular No. A-102 applies to this program. OMB Circular No. A-110 applies to this program. Applications are solicited by a program announcement. The availability of this announcement will be broadly published, including by posting on www.grants.gov. Award Procedure: Following objective review of applications, those applicants whose applications have been selected by the Secretary of HHS (or designee) for funding will receive a Notice of Award signed by an HHS Grants Management Officer. The Notice of Award, which is sent to the applicants Authorized Organizational Representative, is the only official notification of award. Unsuccessful applicants will be advised by letter. Deadlines: Contact the headquarters or regional office, as appropriate, for application deadlines. Range of Approval/Disapproval Time: From 60 to 90 days. Appeals: Not Applicable. Renewals: Not Applicable. Formula and Matching Requirements: This program has no statutory formula. Matching Requirements: In fiscal year 2010, the Secretary of the Department of Health and Human Services will determine whether there is a funding matching requirement. Beginning with fiscal year 2011, the HITECH Act, Section 3013, requires awardees to make available non-Federal contributions (which may include in-kind contributions) toward the costs of a grant awarded in an amount equal to not less than $1 for each $10 of federal funds provided under this grant in fiscal year 2011, not less than $1 for each $7 of federal funds provided under this grant in fiscal year 2012 and not less that $1 for each $3 of federal funds provided under this grant for all subsequent fiscal years. This program does not have MOE requirements. Length and Time Phasing of Assistance: Awards are expected to be for a four year period. See the following for information on how assistance is awarded/released: Subject to meeting performance requirements. Reports: Programmatic reporting requirements will be identified in the Program Announcement. Cash reports, if required, will be identified in the Program Announcement. Recipients of Federal awards from funds authorized under Division A of the ARRA must comply with all requirements specified in Division A of the ARRA (Public Law 111-5), including reporting requirements outlined in Section 1512 of the Act. For purposes of reporting, ARRA recipients must also report on ARRA sub-recipient (sub-grantee and sub-contractor) activities. Reports required by ARRA will be required quarterly. Additional reporting requirements, including the frequency thereof, will be detailed in Funding Opportunity Announcements and included in award notices. Financial Status Reports. ARRA reporting and programmatic reporting will require awardees to evaluate performance in view of stated objectives. Audits: In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. Records: Grantees are required to maintain grant accounting records for a minimum of 3 years from the submission date of the final financial report. If any litigation, claim, negotiation, audit or other action involving the record has been started before the expiration of the 3-year period, the records shall be retained until the completion of the action and resolution of all issues which arise from it or until the end of the regular 3-year period, whichever is later. Account Identification: 75-0130-0-1-551. Obligations: (Cooperative Agreements (Discretionary Grants)) FY 08 $0; FY 09 est $0; FY 10 est $564,000,000 Range and Average of Financial Assistance: Average of each award is estimated at $10.25M. Funds to be fully obligated at time of award, however, draw downs require prior authorization from the program officer. PROGRAM ACCOMPLISHMENTS: Not Applicable. REGULATIONS, GUIDELINES, AND LITERATURE: This program is subject to the provisions of 45 CFR Part 92 for State, local and tribal governments and 45 CFR Part 74 for institutions of higher education, hospitals, other nonprofit organizations and commercial organizations. Regional or Local Office: None. Headquarters Office: Chris Muir 200 Independence Avenue, S.W., Suite 729D , Washington, District of Columbia 20201 Email: christopher.muir@hhs.gov Phone: (202) 205-0470 Website Address: No Data Available RELATED PROGRAMS: Not Applicable. EXAMPLES OF FUNDED PROJECTS: Not Applicable. CRITERIA FOR SELECTING PROPOSALS: Specific, detailed criteria for determining merit of applications will be made available in the funding opportunity guidance document(s) for this program. In general, all applicants are required to demonstrate capability to achieve the goals, purposes, and objectives of the program consistent with applicable statutory provisions. 93.720 ARRA - SURVEY AND CERTIFICATION AMBULATORY SURGICAL CENTER HEALTHCARE-ASSOCIATED INFECTION (ASC-HAI) PREVENTION INITIATIVE ASC-HAI Initiative - Recovery Act FEDERAL AGENCY: Centers for Medicare and Medicaid Services, Department of Health and Human Services AUTHORIZATION: American Recovery and Reinvestment Act of 2009 (Recovery Act), Section 1864 of the Social Security Act. OBJECTIVES: (a) Improve State Agency inspection capability and frequency for onsite surveys of Ambulatory Surgical Centers nationwide; (b) Use a new infection control survey tool developed by the Centers for Disease Control and Prevention and CMS; (c) Improve the survey process through the use of a CMS tracer methodology; and (d) Use multi-person teams for ASCs over a certain size or complexity. Formula Grants (Apportionments) States will use the funding to conduct additional ASC surveys, save and/or create jobs directly within the State Agency; contract with experienced surveyors who will be trained in the new ASC survey process, enlist the services of State physicians or certified infection control specialists who will accompany surveyors on several of their initial surveys conducted under the new survey process. Funding may not be used to support other State Agency work required by CMS and may not be used to offset costs are that funded through CMS regular survey and certification budget. Applicant Eligibility: See Index. Beneficiary Eligibility: See Index. Credentials/Documentation: No Credentials or documentation are required. This program is excluded from coverage under OMB Circular No. A-87. Preapplication Coordination: Any questions about the Recovery Act ASC HAI Initiative or the application process should be directed to Angela Mason-Elbert at 410-786-8279. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372. Application Procedures: This program is excluded from coverage under OMB Circular No. A-102. This program is excluded from coverage under OMB Circular No. A-110. Memorandum S&C-09-43 outlined the Recovery Act ASC-HAI initiative application process. States must submit projected plans and costs eligible for Recovery Act funding. The plans must include the following: |